The federal agency tasked with studying ways to improve America’s outstandingly poor healthcare system is “on the brink,” experts warn. The Trump administration has cut its staff by 75 percent, canceled its grants en masse, and is refusing to spend tens of millions of dollars appropriated by Congress.
Whether the agency “will survive the second Trump administration is an open question,” health policy experts Aaron Carroll and David Atkins wrote in an opinion piece published today in the Annals of Internal Medicine.
The agency in question is the Agency for Healthcare Research and Quality (AHRQ), which has focused on ways to improve patient safety, healthcare quality, care delivery, and new technologies and practices since the 1990s. In the past, “Republican leaders recognized that health care disparities were fundamental quality problems,” Carroll and Atkins wrote. But recently, disparities in care have become partisan issues.
During Trump’s second term, DOGE cuts led to the firing or retirement of an estimated 75 percent of the AHRQ’s staff. In July, AHRQ abruptly sent grant cancellation letters to around 150 researchers. More than 100 research grants collectively worth over $250 million have been canceled. Although Congress appropriated $345 million for the 2026 fiscal year, much of it has gone unspent, with only $15 million going to grants so far. As such, scientists across over 30 states have halted research, laid off staff, shut down programs, and stopped pursuing new lines of research.
“Profound concern”
In addition to the losses in data and research findings, Carroll and Atkins lament the loss to the scientific community. “This is what it looks like when we stop developing the next generation of health services researchers.” Reversing the damage is doable, but will be difficult, they write, while calling on Congress to act.